HomeOXB • LON
add
Oxford BioMedica plc
Previous close
GBX 295.00
Day range
GBX 280.00 - GBX 299.50
Year range
GBX 232.50 - GBX 455.00
Market cap
310.05M GBP
Avg Volume
314.54K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 39.00M | 67.80% |
Operating expense | 21.07M | -19.69% |
Net income | -5.35M | 90.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 681.00K | 104.05% |
Effective tax rate | -5.91% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.65M | -41.52% |
Total assets | 231.64M | -8.20% |
Total liabilities | 171.16M | -1.92% |
Total equity | 60.49M | — |
Shares outstanding | 105.96M | — |
Price to book | 5.46 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.35M | 90.23% |
Cash from operations | -5.73M | 50.37% |
Cash from investing | -827.00K | -261.68% |
Cash from financing | -3.44M | -18.33% |
Net change in cash | -10.38M | 19.27% |
Free cash flow | 907.69K | 111.96% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Founded
1995
Website
Employees
850
